Skip to main content

Immunovant, Inc 10-Q for FY2026 Q3

Immunovant, Inc. (IMVT)

10-Q 2026-02-06 For: 2025-12-31
View Original
Added on April 11, 2026

About this 10-Q

Immunovant, Inc filed this 10-Q on February 6, 2026, covering the quarter ended December 31, 2025 (FY2026 Q3).

Headline figures

Quarter ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$110.64M
compared with a net loss of $111.12M a year earlier
Diluted EPS
-$0.61
compared with -$0.76 a year earlier